Edition:
United Kingdom

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

75.88SEK
22 Feb 2018
Change (% chg)

-0.28kr (-0.37%)
Prev Close
76.16kr
Open
76.10kr
Day's High
77.32kr
Day's Low
75.56kr
Volume
1,731,871
Avg. Vol
1,423,298
52-wk High
95.90kr
52-wk Low
66.12kr

Chart for

About

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer... (more)

Overall

Beta: 0.91
Market Cap(Mil.): kr30,942.93
Shares Outstanding(Mil.): 368.59
Dividend: 0.50
Yield (%): 1.19

Financials

  Industry Sector
P/E (TTM): -- 148.59 16.60
EPS (TTM): -- -- --
ROI: -- 9.38 10.66
ROE: -- 14.72 14.30

BRIEF-Bolivia buys linear accelerators from Elekta

* BOLIVIAN GOVERNMENT INVESTS IN STATE-OF-THE-ART CANCER CARE FROM ELEKTA

21 Feb 2018

BRIEF-Elekta's Gamma Knife system cleared for use by China

* ELEKTA'S LEKSELL GAMMA KNIFE ICON RADIOSURGERY SYSTEM CLEARED FOR USE IN CHINA Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

05 Feb 2018

BRIEF-Elekta signs $29 mln deal with the Ottawa Hospital

* THE OTTAWA HOSPITAL ACQUIRES SEVERAL ELEKTA VERSA HD DEVICES FOR ADVANCED CANCER TREATMENT

31 Jan 2018

BRIEF-Elekta reaches agreement in dispute with Stockholm County Council

* ELEKTA AND STOCKHOLM COUNTY COUNCIL AGREE ON CONSTRUCTIVE WAY FORWARD

12 Dec 2017

UPDATE 1-Elekta delays order target for new radiation therapy machine

STOCKHOLM, Nov 30 Sweden's Elekta pushed back its order target for a new radiation therapy machine which is meant to drive its future sales growth on Thursday as it reported higher quarterly core earnings than expected.

30 Nov 2017

BRIEF-Elekta CEO: Unity radiation therapy system a 2018 sales driver

Nov 30 Elekta AB CEO Richard Hausmann and CFo Gustaf Salford in a conference call with analysts and media:

30 Nov 2017

Elekta postpones order target for new flagship product Unity

STOCKHOLM, Nov 30 Swedish radiotherapy gear maker Elekta on Thursday pushed back its target for order bookings of its new flagship radiation therapy machine Unity as it posted higher quarterly core earnings, but lower order intake, than expected.

30 Nov 2017

BRIEF-Elekta Q2 core profit beat expectations, orders lag

* SAYS ‍OUR TARGETS FOR YEAR ARE CLEAR - WE WILL DELIVER PROFITABLE GROWTH AND REACH AN EBITA MARGIN EXCEEDING 20 PERCENT THROUGH GROWTH AND OUR WORK WITH CONTINUOUS OPERATIONAL IMPROVEMENTS​

30 Nov 2017

BRIEF-Elekta signs £22 mln agrement with UK's National Health Service

* UK'S NATIONAL HEALTH SERVICE SIGNS GBP 22 MILLION AGREEMENT FOR ELEKTA CANCER TREATMENT SYSTEMS

29 Nov 2017

BRIEF-21St century oncology chooses Elekta for replacement of radiation therapy devices

* Elekta announces that 21st Century Oncology, the largest radiation oncology provider in the U.S., will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta. Source text for Eikon: Further company coverage: (Reporting By Johan Ahlander)

21 Nov 2017

Earnings vs. Estimates